Leidos was recently awarded a prime contract by the Advanced Research Projects Agency for Health (ARPA-H). The hybrid firm fixed price/time and materials contract was awarded by the U.S. Department of Health and Human Services (HHS) and has a one-year base period of performance and two one-year options. ARPA-H supports the development of high-impact transformative biomedical and health research as an independent entity of the National Institutes of Health (NIH).

Through this contract, Leidos will provide scalable solutions and resilient systems to the agency's mission accelerating better health outcomes for everyone. The company will provide ARPA-H with a full range of IT support, design, development, and implementation.